证券出售报告
Biodesix(BDSX)02-10 08:15
$Biodesix(BDSX)$ 144 Report of proposed sale of securities Accession Number: 0000905148-24-000542 Act: 33 Size: 4 KB 网页链接
简介：Biodesix, Inc.于2005年在特拉华州成立。该公司是领先的数据驱动型诊断解决方案公司，利用其专有的人工智能（AI）平台利用其最先进的技术来发现，开发和商业化满足临床未满足需求的解决方案，主要关注肺部疾病。
| 今开：1.23 | 昨收：1.26 |
| 最高：1.26 | 最低：1.23 |
| 涨停价： | 跌停价： |
| 总市值：144060705 |
Biodesix(BDSX)02-10 08:15
$Biodesix(BDSX)$ 144 Report of proposed sale of securities Accession Number: 0000905148-24-000542 Act: 33 Size: 4 KB 网页链接
Biodesix(BDSX)02-13 10:55
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000584 Size: 17 KB 网页链接
Biodesix(BDSX)02-13 10:55
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000586 Size: 17 KB 网页链接
Biodesix(BDSX)02-13 10:55
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000583 Size: 17 KB 网页链接
Biodesix(BDSX)04-10 07:35
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001141 Size: 6 KB 网页链接
Biodesix(BDSX)04-10 07:35
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001137 Size: 6 KB 网页链接
Biodesix(BDSX)04-10 07:45
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001142 Size: 5 KB 网页链接
Biodesix(BDSX)04-10 07:45
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001144 Size: 5 KB 网页链接
Biodesix(BDSX)04-05 20:25
$Biodesix(BDSX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-087953 Act: 33 Size: 550 KB 网页链接
Biodesix(BDSX)03-01 07:25
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000822 Size: 5 KB 网页链接
蹊之美股生物医药2021-08-12 21:30
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
CohBar (NASDAQ:CWBR)+25%Allied Healthcare Products (NASDAQ:AHPI)+18%Doximity (NYSE:DOCS)+33%Orphazyme (NASDAQ:ORPH) +16%Fulcrum Therapeutics (NASDAQ:FULC) +7%
Losers:
Biodesix...查看全文
电讯分析员2021-08-05 00:10
$金斯瑞生物科技(01548)$ 感觉中和抗体检测越来越主流化.
图1:新加坡七月底开始介绍金斯瑞CPASS中和抗体检测，
图2:在外打疫苗的新加坡人回国后需要中和抗体检测合格才符合当地规则。
图三:香港可以做中和抗体检测的一些医院。
图四:米国一些上市大型诊所也开始有CPASS可以做中和...查看全文
Tanthius2020-10-29 00:54
$Biodesix(BDSX)$ 中签如中枪呀查看全文
IPO抢先看2020-10-26 08:30
#港美股IPO前瞻#
一、蚂蚁集团、新东方等7家公司通过港交所上市聆讯
1、蚂蚁集团是中国领先的数字支付提供商和领先的数字金融科技平台，其旗下支付宝已成为全球最大的商业类 APP，是中国最大的移动支付平台、最大的线上消费信贷和小微经营者信贷平台、最大的线上保险服务平台、最大的线上...查看全文
chuminhua2020-09-10 22:48
9/8，Aveo Oncology$AVEO制药(AVEO)$ 已重新获得了ficlatuzumab的全部全球权利。2014年，在该药物II期肺癌研究失败后两年，Aveo和Biodesix达成协议，平分药物的成本和利润。Aveo从伴随诊断合作伙伴Biodesix获得财务支持，不过给了双方在首次上市前任何时候退出交易的选择权。现在随着进入III期，Bi...查看全文
$Biodesix(BDSX)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-24-107051 Act: 33 Size: 2 MB 网页链接
$Biodesix(BDSX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-097930 Act: 34 Size: 1 MB 网页链接
$Biodesix(BDSX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-24-018954 Act: 34 Size: 57 KB 网页链接
$Biodesix(BDSX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-24-018955 Act: 34 Size: 88 KB 网页链接
$Biodesix(BDSX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-24-018946 Act: 34 Size: 176 KB 网页链接
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001144 Size: 5 KB 网页链接
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001143 Size: 9 KB 网页链接
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001142 Size: 5 KB 网页链接
$Biodesix(BDSX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-24-018943 Act: 34 Size: 86 KB 网页链接
$Biodesix(BDSX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001136 Size: 5 KB 网页链接